018699683

B

---

May 8, 2022

Trademark Summary

The trademark application b was filed by BridgeBio Pharma, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on June 20, 2022, and it was registered by office on September 27, 2022 without any oppositions.

The application was filed in English (French was selected as the second language).

Change of name and professional address of the trademark registration was recorded on January 3, 2024.

---

Goods And Services

• The mark was filed in class 5 with Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders.
• The mark was filed in class 42 with Pharmaceutical research and development services.